Gene expression omnibus | Type samples | Characteristics\subtype | Number of samples (n) | Original publications |
---|---|---|---|---|
(Accession number) | Â | Â | Â | Â |
GDS2250/GSE7904 | Patients | Normal/non-basal-like/basal | n = 47 | Richardson AL, Wang ZC, De Nicolo A, Lu X et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006 Feb;9(2):121–32. |
GDS1329 | Patients | Apocrine/basal/luminal | n = 49 | Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 2005 Jul 7;24(29):4660–71. |
GSE34211 | Cell lines | Luminal/basal | n = 35 | Hook KE, Garza SJ, Lira ME, Ching KA et al. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735. Mol Cancer Ther 2012 Mar;11(3):710-9 |
GSE12777 | Cell lines | Luminal/basal | n = 49 | Hoeflich KP, O’Brien C, Boyd Z, Cavet G et al. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin Cancer Res 2009 Jul 15; 15(14):4649–64. |